Latest Insider Transactions at Schwab Charles Corp (SCHW)
This section provides a real-time view of insider transactions for Schwab Charles Corp (SCHW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SCHWAB CHARLES CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SCHWAB CHARLES CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.37%
|
$1,800,000
$75.58 P/Share
|
|
Mar 06
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect |
23,258
-100.0%
|
$1,744,350
$75.59 P/Share
|
|
Mar 05
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
9,887
-17.1%
|
$741,525
$75.38 P/Share
|
|
Mar 05
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
15,229
-20.49%
|
$1,142,175
$75.38 P/Share
|
|
Mar 03
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,277
-13.17%
|
$890,883
$79.05 P/Share
|
|
Mar 03
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect |
28,668
-55.21%
|
$2,264,772
$79.32 P/Share
|
|
Mar 03
2025
|
Jonathan M. Craig MD, Head of Investor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
28,668
+100.0%
|
$1,204,056
$42.99 P/Share
|
|
Mar 03
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Payment of exercise price or tax liability
|
Direct |
19,151
-100.0%
|
$1,512,929
$79.05 P/Share
|
|
Mar 03
2025
|
Richard A Wurster President |
SELL
Payment of exercise price or tax liability
|
Direct |
34,608
-15.01%
|
$2,734,032
$79.05 P/Share
|
|
Mar 03
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,380
-5.52%
|
$267,020
$79.32 P/Share
|
|
Mar 03
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,367
-8.77%
|
$265,993
$79.05 P/Share
|
|
Mar 03
2025
|
Walter W Bettinger Co-Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
96,539
-9.17%
|
$7,626,581
$79.05 P/Share
|
|
Mar 03
2025
|
Peter J. Morgan Iii General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,378
-45.15%
|
$661,862
$79.05 P/Share
|
|
Mar 03
2025
|
Charles R. Schwab Co-Chairman |
BUY
Payment of exercise price or tax liability
|
Direct |
26,075
+100.0%
|
$2,059,925
$79.05 P/Share
|
|
Mar 01
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Payment of exercise price or tax liability
|
Direct |
2,088
-4.49%
|
$164,952
$79.05 P/Share
|
|
Mar 01
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
9,482
+16.95%
|
-
|
|
Mar 01
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,506
+23.64%
|
-
|
|
Mar 01
2025
|
Jonathan M. Craig MD, Head of Investor Services |
BUY
Grant, award, or other acquisition
|
Direct |
42,409
+50.0%
|
-
|
|
Mar 01
2025
|
Richard A Wurster President |
BUY
Grant, award, or other acquisition
|
Direct |
92,770
+28.7%
|
-
|
|
Mar 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,254
+25.66%
|
-
|
|
Mar 01
2025
|
Walter W Bettinger Co-Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
225,295
+17.63%
|
-
|
|
Mar 01
2025
|
Peter J. Morgan Iii General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
18,554
+50.0%
|
-
|
|
Mar 01
2025
|
Charles R. Schwab Co-Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
66,263
+50.0%
|
-
|
|
Feb 27
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
55,598
-0.09%
|
$4,392,242
$79.14 P/Share
|
|
Feb 24
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
87,500
-0.22%
|
-
|
|
Feb 21
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
124,000
-0.1%
|
$10,168,000
$82.13 P/Share
|
|
Feb 19
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
124,000
-0.21%
|
$10,044,000
$81.96 P/Share
|
|
Feb 18
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
5,865
-0.01%
|
$475,065
$81.4 P/Share
|
|
Feb 13
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
125,000
-0.1%
|
$10,125,000
$81.4 P/Share
|
|
Feb 12
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
180,506
-0.3%
|
$14,801,492
$82.09 P/Share
|
|
Feb 12
2025
|
Charles R. Schwab Co-Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
180,506
+100.0%
|
$5,415,180
$30.17 P/Share
|
|
Feb 12
2025
|
Walter W Bettinger Co-Chairman |
SELL
Open market or private sale
|
Direct |
464,629
-18.44%
|
$38,099,578
$82.27 P/Share
|
|
Feb 12
2025
|
Walter W Bettinger Co-Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
464,629
+26.45%
|
$12,080,354
$26.39 P/Share
|
|
Feb 06
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.35%
|
$1,968,000
$82.7 P/Share
|
|
Jan 23
2025
|
Arun Sarin Director |
SELL
Open market or private sale
|
Indirect |
8,548
-31.47%
|
$692,388
$81.82 P/Share
|
|
Jan 23
2025
|
Arun Sarin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,548
+48.15%
|
$264,988
$31.21 P/Share
|
|
Jan 22
2025
|
Peter J. Morgan Iii General Counsel |
SELL
Open market or private sale
|
Direct |
14,643
-100.0%
|
$1,171,440
$80.7 P/Share
|
|
Jan 22
2025
|
Peter J. Morgan Iii General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,643
+50.0%
|
$600,363
$41.98 P/Share
|
|
Jan 02
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.33%
|
$1,776,000
$74.14 P/Share
|
|
Dec 18
2024
|
Stephen A Ellis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,550
+32.32%
|
$376,500
$30.45 P/Share
|
|
Dec 16
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
9,000
-0.5%
|
$711,000
$79.29 P/Share
|
|
Nov 26
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Bona fide gift
|
Indirect |
320
-0.02%
|
-
|
|
Nov 25
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
2,300
-11.29%
|
$188,600
$82.01 P/Share
|
|
Nov 25
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
2,300
+5.86%
|
$101,200
$44.24 P/Share
|
|
Nov 22
2024
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
12,739
-17.73%
|
$1,031,859
$81.17 P/Share
|
|
Nov 18
2024
|
Christopher V Dodds Director |
SELL
Open market or private sale
|
Indirect |
9,284
-2.05%
|
$752,004
$81.43 P/Share
|
|
Nov 18
2024
|
Christopher V Dodds Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,284
+33.48%
|
$352,792
$38.31 P/Share
|
|
Nov 15
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
9,000
-0.49%
|
$720,000
$80.03 P/Share
|
|
Nov 14
2024
|
Stephen A Ellis Director |
SELL
Bona fide gift
|
Indirect |
35,316
-31.74%
|
-
|
|
Nov 14
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
2,700
-13.0%
|
$218,700
$81.68 P/Share
|